MedTrace Logo

The Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery

NCT02122497 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2014-04-24

No results posted yet for this study

Summary

The aim of the present study is the evaluation of cardiovascular biomarkers in patients with abdominal aortic aneurysms (AAA) or abdominal aortic occlusive disease AOD) undergoing open (OR) or endovascular aortic repair (EVAR) with regards to short- and long-term outcome.

By blood collection and measurement of the serum biomarkers Copeptin, N-terminal- pro Brain Natriuretic Peptide (NT-proBNP), cardiac Troponin I (cTnI), high sensitive Troponin T (hs-cTnT) and C-reactive Protein (CRP) we expect an improvement of patients stratification by assessment of cardiac stress tolerance. Data gathered may help to simplify the decision whether an open or endovascular approach for abdominal aortic repair (OR and EVAR) should be performed.

Study Hypothesis:

The evaluation of the predictive value of cardiovascular biomarkers (Copeptin, NT-proBNP, hsTnT, cTnI, CRP) improve patient stratification and selection of surgical treatment.

Conditions

  • Aortic Aneurysm, Abdominal
  • Arterial Occlusive Diseases

Interventions

PROCEDURE

abdominal aortic surgery

Sponsors & Collaborators

  • Wilhelminenspital Vienna

    collaborator OTHER

  • Prim PD Dr Afshin Assadian

    lead OTHER

Principal Investigators

  • Afshin Assadian, PD Dr. · Department of Vascular and Endovascular Surgery, Wilhelminenhospital Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02122497 on ClinicalTrials.gov